77 related articles for article (PubMed ID: 33909674)
1. Incidence and risk factors of VTE in patients with cervical cancer using the Korean national health insurance data.
Yuk JS; Lee B; Kim MH; Kim K; Seo YS; Hwang SO; Cho YK; Kim YB
Sci Rep; 2021 Apr; 11(1):8031. PubMed ID: 33850221
[TBL] [Abstract][Full Text] [Related]
2. Implementation of routine venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer.
McLaughlin HD; Greco P; Straubhar AM; Rolston A; McCool K; Brackmann M; Siedel JH; McLean K; Reynolds RK; Uppal S
Gynecol Oncol; 2023 Nov; 178():89-95. PubMed ID: 37832182
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program.
Graul A; Latif N; Zhang X; Dean LT; Morgan M; Giuntoli R; Burger R; Kim S; Ko E
Int J Gynecol Cancer; 2017 Mar; 27(3):581-587. PubMed ID: 28187092
[TBL] [Abstract][Full Text] [Related]
4. Late venous thromboembolism in survivors of adolescent and young adult cancer: A population-based study in California.
Abrahão R; Brunson A; Chubak J; Wernli KJ; Nichols HB; Chao C; Ruddy KJ; Hahn EE; Li Q; Malogolowkin MH; Sauder CAM; Kushi LH; Wun T; Keegan THM
Thromb Res; 2024 Mar; 235():1-7. PubMed ID: 38244373
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism risk in cancer patients receiving first-line immune checkpoint inhibitor versus chemotherapy.
Li A; May SB; La J; Martens KL; Amos CI; Flowers CR; Do NV; Brophy MT; Chitalia V; Ravid K; Gaziano JM; Fillmore NR
Am J Hematol; 2023 Aug; 98(8):1214-1222. PubMed ID: 37161855
[TBL] [Abstract][Full Text] [Related]
6. Risk and Timing of Venous Thromboembolism After Surgery for Lung Cancer: A Nationwide Cohort Study.
Mørkved AL; Søgaard M; Skjøth F; Ording AG; Jensen M; Larsen TB; Jakobsen E; Højen AA; Noble S; Meldgaard P; Petersen RH; Christensen TD
Ann Thorac Surg; 2024 Feb; 117(2):289-296. PubMed ID: 37890818
[TBL] [Abstract][Full Text] [Related]
7. Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancer.
Boerner T; Lam C; Basaran D; Liu YL; Grisham RN; Tew WP; Long Roche K; Zivanovic O; Abu-Rustum NR; Gardner GJ; Sonoda Y; Chi DS; Soff G; Jewell E
Int J Gynecol Cancer; 2023 Dec; ():. PubMed ID: 38088180
[TBL] [Abstract][Full Text] [Related]
8. Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy.
Basaran D; Boerner T; Suhner J; Sassine D; Liu Y; Grisham RN; Tew WP; Gardner GJ; Zivanovic O; Sonoda Y; Long Roche K; Chi DS; Abu-Rustum NR; Soff GA; Jewell EL
Gynecol Oncol; 2021 Oct; 163(1):36-40. PubMed ID: 34312001
[TBL] [Abstract][Full Text] [Related]
9. Incidence and patient characteristics of venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer.
Chokshi SK; Gaughan JP; Krill L
J Thromb Thrombolysis; 2022 Jan; 53(1):202-207. PubMed ID: 34185227
[TBL] [Abstract][Full Text] [Related]
10. Incidence Rates of Myomectomy-Related Mortality and Venous Thromboembolism in South Korea: A Population-Based Study.
Yuk JS; Kim M
Front Med (Lausanne); 2022; 9():849660. PubMed ID: 35360731
[TBL] [Abstract][Full Text] [Related]
11. Gynecological Cancer and Venous Thromboembolism: A Narrative Review to Increase Awareness and Improve Risk Assessment and Prevention.
Falanga A; Lorusso D; Colombo N; Cormio G; Cosmi B; Scandurra G; Zanagnolo V; Marietta M
Cancers (Basel); 2024 May; 16(9):. PubMed ID: 38730721
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant Chemotherapy is Associated with Increased Risk of Postoperative DVT After Distal Pancreatectomy for Pancreatic Adenocarcinoma: a NSQIP Analysis.
Robbins KJ; Newcomer KF; Barnell EK; Anzelmo MA; Liu J; Hawkins WG
Ann Surg Oncol; 2024 May; 31(5):2873-2881. PubMed ID: 38151621
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors for venous thromboembolism in patients with ovarian cancer during neoadjuvant chemotherapy: a meta-analysis.
Han L; Chen Y; Zheng A; Chen H
Am J Cancer Res; 2023; 13(5):2126-2134. PubMed ID: 37293158
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk of venous thromboembolism according to primary treatment in women with ovarian cancer: A retrospective cohort study.
Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Yoon SH; Kim YB
PLoS One; 2021; 16(4):e0250723. PubMed ID: 33909674
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk of venous thromboembolism according to primary treatment type in women with endometrial cancer: a population-based study.
Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Cho YK; Kim YB
BMC Cancer; 2021 Oct; 21(1):1166. PubMed ID: 34717579
[TBL] [Abstract][Full Text] [Related]
16. Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in Korea.
Shin W; Lee S; Lim MC; Jung J; Kim HJ; Cho H
Cancer Med; 2021 Mar; 10(6):2045-2053. PubMed ID: 33638309
[TBL] [Abstract][Full Text] [Related]
17. Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer.
Chavan DM; Huang Z; Song K; Parimi LRH; Yang XS; Zhang X; Liu P; Jiang J; Zhang Y; Kong B; Li L
Medicine (Baltimore); 2017 Oct; 96(42):e7935. PubMed ID: 29049188
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
